Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acute liver failure.

Literature DB >> 1916476

Acute liver failure.

R D Hughes¹, J Wendon, A E Gimson.

Abstract

Entities: Disease

Mesh：

Year: 1991 PMID： 1916476 PMCID： PMC1405220 DOI： 10.1136/gut.32.suppl.s86

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

23 in total

1. A study in vitro of the sodium pump in fulminant hepatic failure.

Authors: A N Alam; L Poston; S P Wilkinson; C G Golindano; R Williams
Journal: Clin Sci Mol Med Date: 1978-10

2. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

Authors: P M Harrison; R Keays; G P Bray; G J Alexander; R Williams
Journal: Lancet Date: 1990-06-30 Impact factor: 79.321

3. Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

Authors: B G Gazzard; M J Weston; I M Murray-Lyon; H Flax; C O Record; R Williams; B Portmann; P G Langley; E H Dunlop; P J Mellon; M B Ward
Journal: Lancet Date: 1974-06-29 Impact factor: 79.321

4. Earlier charcoal haemoperfusion in fulminant hepatic failure.

Authors: A E Gimson; S Braude; P J Mellon; J Canalese; R Williams
Journal: Lancet Date: 1982-09-25 Impact factor: 79.321

5. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.

Authors: B G Gazzard; B Portmann; I M Murray-Lyon; R Williams
Journal: Q J Med Date: 1975-10

6. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.

Authors: C D Gove; R D Hughes; R Williams
Journal: Br J Exp Pathol Date: 1982-10

7. Reticuloendothelial system and hepatocytic function in fulminant hepatic failure.

Authors: J Canalese; C D Gove; A E Gimson; S P Wilkinson; E N Wardle; R Williams
Journal: Gut Date: 1982-04 Impact factor: 23.059

8. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.

Authors: J Canalese; A E Gimson; C Davis; P J Mellon; M Davis; R Williams
Journal: Gut Date: 1982-07 Impact factor: 23.059

9. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.

Authors: D Vergani; G Mieli-Vergani; A Alberti; J Neuberger; A L Eddleston; M Davis; R Williams
Journal: N Engl J Med Date: 1980-07-10 Impact factor: 91.245

Acute liver failure.

1. A study in vitro of the sodium pump in fulminant hepatic failure.

2. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine.

3. Charcoal haemoperfusion in the treatment of fulminant hepatic failure.

4. Earlier charcoal haemoperfusion in fulminant hepatic failure.

5. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage.

6. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure.

7. Reticuloendothelial system and hepatocytic function in fulminant hepatic failure.

8. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure.

9. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis.

10. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.

1. Liver failure induced by paracetamol.

2. Antithrombin as a marker of severe acute hepatitis B.

3. Structured approach to treat patients with acute liver failure: A hepatic emergency.

4. Acetaminophen toxicity: suicidal vs. accidental.

5. MRI-based assessment of liver perfusion and hepatocyte injury in the murine model of acute hepatitis.